Nobuyuki Itoh

Title: Inventor Profile: Nobuyuki Itoh

Introduction: Nobuyuki Itoh is a prominent inventor based in Kyoto, Japan, recognized for his contributions to the field of biotechnology. With a total of four patents to his name, Itoh has made significant advancements in understanding and utilizing human fibroblast growth factors.

Latest Patents: His latest inventions focus on the human FGF-21 gene and its expression products. The primary patent describes human fibroblast growth factor (hFGF-21) and its variants, along with polynucleotides encoding FGF-21. This invention is pivotal for developing diagnostic and therapeutic agents related to liver diseases such as cirrhosis and cancer. Moreover, it encompasses methods for treating conditions associated with thymic function and testis-related ailments. Additionally, the invention includes mouse fibroblast growth factor (mFGF-21) and its variants.

Career Highlights: Throughout his career, Nobuyuki Itoh has collaborated with leading institutions, including Kyoto University, which has served as a significant platform for his research and innovation. His work has been instrumental in bridging the gap between genetic research and practical medical applications.

Collaborations: Itoh has worked alongside notable individuals such as Michael Kavanaugh and W. Michael Kavanaugh, contributing to many of his innovative projects. These collaborations have enriched his research and expanded the impact of his inventions in the biotechnology field.

Conclusion: Nobuyuki Itoh's contributions to the field of biotechnology, particularly through his patents on human fibroblast growth factors, highlight his role as a leading inventor in Japan. His work continues to inspire advancements in medical diagnostics and therapeutics, making significant strides in treating complex diseases.